Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;22(2):54.
doi: 10.1208/s12249-021-01923-0.

Exploratory Study on Lercanidipine Hydrochloride Polymorphism: pH-Dependent Solubility Behavior and Simulation of its Impact on Pharmacokinetics

Ilia Alekseevich Repin  1 , Raimar Loebenberg  2 , John DiBella  3 , António C L Conceição  4 , Manuel E Minas da Piedade  5 , Humberto G Ferraz  1 , Michele G Issa  1 , Nadia A Bou-Chacra  1 , Catharine F M Ermida  1 , Gabriel L B de Araujo  6
Affiliations

Exploratory Study on Lercanidipine Hydrochloride Polymorphism: pH-Dependent Solubility Behavior and Simulation of its Impact on Pharmacokinetics

Ilia Alekseevich Repin et al. AAPS PharmSciTech. .

Abstract

This work describes an exploratory experimental and in silico study of the influence of polymorphism, particle size, and physiology on the pharmacokinetics of lercanidipine hydrochloride (LHC). Equilibrium and kinetic solubility studies were performed on LHC forms I and II, as a function of pH and buffer composition. GastroPlus® was used to evaluate the potential effect of solubility differences due to polymorphism, particle size, and physiological conditions, on the drug pharmacokinetics. The results indicated that solubilities of LHC polymorphs are strongly dependent on the composition and pH of the buffer media. The concentration ratio (CI/CII) is particularly large for chloride buffer (CI/CII = 3.3-3.9) and exhibits a slightly decreasing tendency with the pH increase for all other buffers. Based on solubility alone, a higher bioavailability of form I might be expected. However, exploratory PBPK simulations suggested that (i) under usual fasted (pH 1.3) and fed (pH 4.9) gastric conditions, the two polymorphs have similar bioavailability, regardless of the particle size; (ii) at high gastric pH in the fasted state (e.g., pH 3.0), the bioavailability of form II can be considerably lower than that of form I, unless the particle size is < 20 μm. This study demonstrates the importance of investigating the effect of the buffer nature when evaluating the solubility of ionizable polymorphic substances. It also showcases the benefits of using PBPK simulations, to assess the risk and pharmacokinetic relevance of different solubility and particle size between crystal forms, for diverse physiological conditions.

Keywords: PBPK simulation; lercanidipine hydrochloride; pharmacokinetics; polymorphism; solubility.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Souza JB, Souza JD, Castro LM, Siqueira MF, Savedra RM, Silva-Barcellos NM. Evaluation of the losartan solubility in the biowaiver context by shake-flask method and intrinsic dissolution. Pharm Dev Technol. 2019;24(3):283–92. - PubMed
    1. Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm. 2000;50(1):3–12. - PubMed
    1. Thabet TY, Klingmann V, Breitkreutz J. Drug formulations: standards and novel strategies for drug administration in pediatrics. J Clin Pharmacol. 2018;58:S26–35. - PubMed
    1. Censi R, Di Martino P. Polymorph impact on the bioavailability and stability of poorly soluble drugs. Molecules. 2015;20(10):18759–76. - PubMed - PMC
    1. Domingos S, André V, Quaresma S, Martins IC. Minas da Piedade MF, Duarte MT. New forms of old drugs: improving without changing. J Pharm Pharmacol. 2015;67(6):830–46. - PubMed

LinkOut - more resources